Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patients

Cytotherapy

Volumn 1, Issue 6, 1999, Pages 447-453

  Toungouz, M ^a   Quinet, C ^a   Thille, E ^a   Fourez, S ^a   Pradier, O ^a   Delville, J P ^a   Velu, T ^a   Lambermont, M ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cancer immunotherapy; Clinical grade; Dendritic cell

Indexed keywords

EID: 21544470687     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/0032472031000141304     Document Type: Article

References (13)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-6.
2. Schuler G, Steinman R. Dendritic cells as adjuvants to immune-mediated resistance to tumors. J Exp Med 1997; 18:1183-7.
3. Santiago-Schwarz F, Belios E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leuk Biol 1992;52:274-81.
4. Sallusto F and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and down regulated by tumor necrosis factor-α J Exp Med 1994;179:1109-18.
5. + blood progenitors for anti-cancer therapy. Exp Hematol 1995; 23:1463-71.
6. Hsu FJ, Benike C, Fagnoni F et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat .Med 1996;2:52-8.
7. Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
8. Murphy G, Tjoa B, Ragde H et al. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996;29:371-80.
9. Thurner B, Röder C, Dieckman D et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999;223:1-15.
10. Toungouz M, Lambermont M, Libin M et al. Detection of IFN-γ secreting T cells after vaccination with clinical grade DC pulsed with MAGE peptides. J Leukocyte Biol 1998; suppl 2:100.
11. Foy TM, Aruffo A, Bajorah J et al. Immune regulation by CD40 and its ligand. Annu Rev Immunol 1996;14:591-617.
12. Cella M, Engering A, Pinet V et al. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-7.
13. Rieser C, Papesh C, Herold M et al. Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-α and prostaglandin E2. Blood 1998; 91:3112-17.